Can increased thyroid hormone signaling raise SHBG and lower free testosterone despite normal or high total testosterone?

An assessment of the relationship between thyroid hormone signaling, sex hormone-binding globulin (SHBG), and testosterone dynamics reveals a highly coordinated endocrine pathway.

Clinical and effectiveness evidence

• Thyroid-SHBG correlation: Serum thyroid hormone levels are independent, positive determinants of circulating SHBG. Clinical studies show that states of thyroid excess (hyperthyroidism) markedly elevate SHBG, while hypothyroidism reduces it. This relationship persists across the subclinical and euthyroid ranges, where free thyroxine ($FT_4$) levels correlate directly with circulating SHBG concentrations.
• Impact on free testosterone: High circulating SHBG binds testosterone with exceptionally high affinity ($K_d \approx 10^{-9}\text{ M}$). As SHBG levels rise, the equilibrium shifts, sequestering a larger fraction of total testosterone. Consequently, free (unbound) testosterone is depleted, even when total testosterone remains normal ($>300\text{ ng/dL}$) or high. Large-scale clinical evaluations, such as the European Male Ageing Study, confirm that patients with elevated SHBG can experience classic symptoms of androgen deficiency—such as decreased libido, erectile dysfunction, and loss of vigor—despite having reassuring total testosterone levels.

Mechanistic explanations

• Transcriptional regulation: Thyroid hormone ($T_3$) upregulates hepatic SHBG gene expression. This is not driven by the direct binding of the thyroid hormone receptor (TR$\beta$1) to a classical thyroid response element on the SHBG promoter. Instead, $T_3$ alters hepatic transcription factor networks and chromatin accessibility.
• Role of HNF4$\alpha$: $T_3$ signaling enhances the activity and expression of hepatocyte nuclear factor 4$\alpha$ (HNF4$\alpha$), the primary transcriptional activator of the proximal human SHBG promoter. Elevated HNF4$\alpha$ binding to the promoter directly upregulates transcription, resulting in increased synthesis and secretion of SHBG by hepatocytes into the bloodstream.

Clinical implications

• Diagnostic limitations: Relying solely on total testosterone can easily miss functional hypogonadism in patients with high thyroid hormone signaling (or those on thyroid hormone replacement therapy).
• Testing recommendations: In patients presenting with signs of androgen deficiency alongside high-normal thyroid function, clinicians must measure SHBG and calculate free testosterone (using the Vermeulen formula) or measure free testosterone directly via equilibrium dialysis to obtain an accurate assessment of androgen status.

Bottom line

Higher thyroid hormone signaling upregulates hepatic SHBG gene expression through HNF4$\alpha$-mediated transcriptional pathways. The resulting increase in circulating SHBG binds testosterone with high affinity, reducing the biologically active free testosterone fraction and potentially causing symptomatic androgen deficiency even when total testosterone is normal or high.